Capping Off The Rebate Debate: Will 2019 Price Push End With Co-Pay Cap?

The pharmaceutical industry and its strongest critics have long agreed on one thing: Medicare Part D would be improved if there was a cap on spending by beneficiaries. Now, there is an unlikely path that may make it surprisingly easy to get it done.

Smooth Focus,There is no money left in the bag, only the credit card that is used to the full limit and cannot be used to buy the necessary items because of wrong money management
Seniors might find more money in their wallets if Congress can agree to a co-pay cap for Part D.

A US House Energy & Commence/Health Subcommittee hearing on prescription drug coverage under Medicare offered a public reminder that there remains strong bipartisan support for capping out of pocket costs for Part D beneficiaries.

While the 30 April hearing, “Prescription Drug Coverage in the Medicare Program,” was broader in scope than what seniors...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access